ABT
Abbott LaboratoriesHealthcare · $174.7B market cap
Verdict
Share price
$97.50
close of Oct 3, 2026
Fair value
$56.90
Sticker Price
Payback Price
$22.76
buy price
ABT is Overpriced: at $97.50 it trades 71% above its fair value of $56.90. Its buy price (Payback Price) is $22.76, 77% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.
How we valued it
Dividend Discount Model. It has paid a dividend for 10+ years in a row, raised it most years, and yields over 2%. For a steady payer like this, the dividend is the best guide to value.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow ABT
Get notified when it reaches its buy price of $22.76. Free.
Create a free accountSuperinvestors
7 of the investors we track hold ABT. In Q2 2026, 2 opened a position, 2 trimmed and 1 sold out. Who we track
Jensen Investment Management
Jensen Investment Management · as of Q2 2026
$80.3M
885,262 shares
Mason Hawkins
Southeastern Asset Management · as of Q2 2026
$76.3M
840,747 shares
Mairs & Power Funds
Mairs & Power Funds · as of Q2 2026
$66.2M
729,358 shares
David Katz
Matrix Asset Advisors · as of Q2 2026
$4.3M
47,262 shares
Dodge & Cox Funds
Dodge & Cox Funds · as of Q2 2026
$1.6M
17,324 shares
Moves in Q2 2026
New position: Mason Hawkins, David Katz
Trimmed: Polen Capital Management, Jensen Investment Management
Sold out: Lee Ainslie
Insider activity
Since May 7, 2026: 1 open-market purchase worth $174K, 4 sales worth $46.9M and 12 other filings (stock awards, tax withholding and similar). Why purchases matter
Purchases
Sales
MCCOY JOHN A. JR.
VICE PRESIDENT AND CONTROLLER · 2026-09-02
Sold
$3K
Ford Robert B
CHAIRMAN AND CEO · 2026-08-25
Sold
$20.9M
Ford Robert B
CHAIRMAN AND CEO · 2026-08-25
Sold
$25.3M
Morrone Louis H.
EXECUTIVE VICE PRESIDENT · 2026-08-11
Sold
$643K
Other filings
Boudreau Philip P
EVP AND CFO · 2026-09-01
Tax withholding
$43K
MCCOY JOHN A. JR.
VICE PRESIDENT AND CONTROLLER · 2026-09-01
Tax withholding
$6K
Ford Robert B
CHAIRMAN AND CEO · 2026-08-25
Option exercise
$6.7M
Ford Robert B
CHAIRMAN AND CEO · 2026-08-25
Option exercise
$14.8M
Morrone Louis H.
EXECUTIVE VICE PRESIDENT · 2026-08-12
I-Discretionary
$1K
Show all 12 other filingsShow fewer
Morrone Louis H.
EXECUTIVE VICE PRESIDENT · 2026-06-30
Tax withholding
$25K
Conroy Kevin T
director · 2026-06-30
Award
231 shares
Gonzalez Patricia Paola
director · 2026-06-30
Award
363 shares
Roman Michael F
director · 2026-06-30
Award
416 shares
Stratton John G
director · 2026-06-30
Award
432 shares
Ahuja Nita
director · 2026-06-30
Award
347 shares
Cushman Elizabeth C.
EVP, GC AND SECRETARY · 2026-06-27
Tax withholding
$53K
About Abbott Laboratories
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products…
Medical - Devices
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works